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ABSTRACT This study examined the degradation pat-
ternof amurine IgG1kmonoclonal antibody expressed in
and extracted from transformed Nicotiana tabacum. Gel
electrophoresis of leaf extracts revealed a consistent pat-
tern of recombinant immunoglobulin bands, including
intact and full-length antibody, as well as smaller antibody
fragments. N-terminal sequencing revealed these smaller
fragments to be proteolytic cleavage products and identi-
ﬁed a limited number of protease-sensitive sites in the
antibody light and heavy chain sequences. No strictly
conserved target sequence was evident, although the
peptide bonds that were susceptible to proteolysis were
predominantly and consistently located within or near to
the interdomain or solvent-exposed regions in the antibody
structure. Amino acids surrounding identiﬁed cleavage
sites were mutated in an attempt to increase resistance.
Different Guy’s 13 antibody heavy and light chain mutant
combinations were expressed transiently in N. tabacum
and demonstrated intensity shifts in the fragmentation pat-
tern, resulting in alterations to the full-length antibody-to-
fragment ratio. The work strengthens the understanding of
proteolytic cleavage of antibodies expressed in plants and
presents a novel approach to stabilize full-length antibody
by site-directed mutagenesis.—Hehle, V. K., Paul, M. J.,
Roberts, V. A., van Dolleweerd, C. J., Ma, J. K.-C. Site-
targeted mutagenesis for stabilization of recombinant mono-
clonal antibody expressed in tobacco (Nicotiana tabacum)
plants. FASEB J. 30, 1590–1598 (2016). www.fasebj.org
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Plant biotechnology has become widely used for recombi-
nant pharmaceutical protein expression (molecular
pharming) since proof of concept over 25 yr ago (1). The
ﬁeld has advanced swiftly, with the ﬁrst U.S. Food and
DrugAdministration drug approved in 2012: taliglucerase
alfa (Elelyso), an enzyme produced in carrot cell sus-
pension culture for treatment of Gaucher disease (2), as
well as a number of products in clinical trials (3, 4). Re-
cently, aplant-producedexperimentalmonoclonal antibody
cocktail, ZMapp, was provided for compassionate use to
treat humans infected with the Ebola virus.
Monoclonal antibodies have been the focus of atten-
tion formany groups, but a number of difﬁculties still need
to be addressed in order to maximize antibody yield from
plant manufacturing systems. In particular, the quality
of plant-derived IgG monoclonal antibodies can be dra-
matically affected by unintended proteolysis, and this has
beenobserved inbothstable transgenicplant and transient
expression systems (5). Relatively little is known about
the speciﬁcity of antibody degradation in plants. Western
blot analysis of recombinant mAbs expressed in plants in-
variably revealed a number of immunoreactive bands in
addition to the putative full-length antibody (5–7). Pre-
viously these bands have been explained as incomplete or
partial assembly intermediates of the immunoglobulin
heavy and light chains (8, 9) on the basis of previously
identiﬁed assembly intermediates from murine lymphoid
and malignant plasma cells (10). However, more recently,
it has been demonstrated that many of the detected frag-
ments are actually degradation products that detract sig-
niﬁcantly from the productivity of the expression system
(5, 7). A variety of attempts have been made to overcome
this problem—for example, by inclusion of protease in-
hibitors in extraction buffer or by coexpression of protease
inhibitors (11–13). Protease activity in vivo may also be
inhibited by gene silencing strategies (14). Methods for
improving transcription and translation levels have been
investigated (15, 16), as have methods for enhancing the
stability of the product protein (17), by targeting the
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antibodies to speciﬁc subcellular compartments (18, 19),
by glycan engineering (20) or by fusing other proteins to
the antibody (21, 22).
However, none of these approaches has been able to
signiﬁcantly reduce proteolysis. It has been shown that
recombinant antibodies, depending on their primary se-
quence, structural characteristics, and subcellular localiza-
tion, are likely to contain amino acid sequences that are
targeted by peptidases in plant cells (5, 7, 23), particularly as
theseheterologousproteinshaveneverevolvedinthecontext
of the host protease environment. It has been demonstrated
that there are only a limited number of plant proteolytic
cleavage events in human immunoglobulin light and heavy
chains, and that thesewereusually focused at exposed sites of
interdomain regions of each immunoglobulin chain (5).
Endopeptidases show a variety of sequence speciﬁcities
surrounding the cleavage site. Some cleave polypeptides
at speciﬁc motifs, which in turn are characteristic of the
peptidase, while others show a very broad recognition
spectrum (24). For example, trypsin cleaves exclusively
afterLys orArg residues (at P1) (25). Prolineusually blocks
this action when found in position P19, carboxyterminal of
the scissile bond. In contrast, the plant proteases pepsin
and papain have fairly broad speciﬁcity (24).
Amino acid mutations that confer resistance to pro-
teolysis might have a measurable effect on the antibody
fragmentation pattern. Expression of antibodies incor-
porating these mutations might therefore result in sim-
pliﬁed antibody puriﬁcation from plants and improved
yields of fully assembled, functional mAbs. In the present
study, an approach consisting of engineering protease
resistance into antibody sequences by targeting suscepti-
ble cleavage sites was explored. Amino acids surrounding
the identiﬁed cleavage sites weremodiﬁed, with the aimof
preventing proteolytic degradation of plant expressed
mAb Guy’s 13. It was demonstrated that mutations of
residues immediately proximal to identiﬁed cleavage sites
modulate, but not completely eliminate, proteolytic deg-
radation of monoclonal antibody.
MATERIALS AND METHODS
Transgenic plant material
Transgenic Nicotiana tabacum (var. Petit Havana) lines homozy-
gous for both the g1 heavy and k light chain genes of the murine
IgG1kmAb Guy’s 13 (26) were used.
Mutagenesis of mAb Guy’s 13 heavy and light chain
The g1 heavy and k light chain genes of mAb Guy’s 13 had
previously been cloned between the XhoI and EcoRI sites of
pL32, and clones, designated g1#3 and K4.1, were used in this
study (26). Using the QuikChange (Agilent Technologies,
Santa Clara, CA, USA) mutagenesis protocol according to the
manufacturer’s instructions, oligonucleotide primers (Sup-
plemental Data) were used to introduce site-directed muta-
tions. Overlapping regions of the heavy or light chain were
ampliﬁed. PCR products were annealed via their common
overlap and ampliﬁed in a second PCR reaction, then puriﬁed
and ligated into plant expression vector pL32. After trans-
formation of Escherichia coli XL10-Gold (Agilent Technolo-
gies), individual colonies were screened by digestion with the
appropriate restriction enzymes (Supplemental Table 1) for each
individual mutant. Putative mutants identiﬁed by this analytical re-
striction enzyme digest were conﬁrmed by sequencing (Beckman
Coulter Genomics, Bishop’s Stortford, United Kingdom) before
transformation of Agrobacterium tumefaciens EHA105.
Transient expression in N. tabacum by agroinﬁltration
For transient expression, the heavy and light chain genes of mAb
Guy’s 13 were expressed from a plant transformation vector
(pL32)(26).Wild-type (WT)N. tabacumplantswere cultivated for
10 to 11 wk from seed. Recombinant A. tumefaciens cultures
EHA105 harboring the light and heavy chains of Guy’s 13 were
grown overnight at 28°C, with shaking at 250 rpm, in Luria
Bertani medium supplemented with spectinomycin (200 mg/ml)
and rifampicin (100mg/ml). Cultures were centrifuged for 5min
at 8000 g, and for coinﬁltration of heavy and light chains, aliquots
of resuspended cell pellets (in Murashige and Skoog medium)
were combined to give a total volume of 1.5 ml. The bacterial
solution was injected directly using a syringe pressed ﬁrmly
against the abaxial surface of a leaf (27). The plants were left to
recover under standard growth conditions (temperature 25°C,
16/8 h light/dark cycle) for 5 to 7 d before leaves were harvested
for analysis of the recombinant protein.
Extraction of mAbs from transgenic and transiently
expressed agroinﬁltrated tobacco plants
Tissue from mature leaves of transgenic tobacco plants
expressingmAbGuy’s 13 were homogenized with 3 volumes of
PBS at room temperature. After 2 cycles of 20 s of homogeni-
zation using a blender (Waring Laboratory Science, Stamford,
CT, USA), the plant extract was centrifuged at 17,000 g
for 30 min at 10°C. The supernatant was passed through
Whatman #3 ﬁlter paper (Whatman PLC, Maidstone, United
Kingdom) and immediately placed on ice. The pH of the ﬁl-
tered plant juice was adjusted to 7.5 to 8.0 with 1MNaOH and
incubated for at least 30 min on ice, followed by recen-
trifugation at 40,000g for 20 min at 10°C. The supernatant was
ﬁltered through a 0.22 mm Millex GP Filter (Millipore, Con-
sett, United Kingdom) and stored at 220°C until required. For
antibody puriﬁcation from agroinﬁltrated N. tabacum plants,
inﬁltrated leaves were sampled and homogenized for 5min at 29
oscillationsper secondusing aMixerMillMM400 (Retsch,Haan,
Germany). Samples were centrifuged at 17,000 g for 10 min
at 10°C and the supernatant stored at220°C until required.
For afﬁnity puriﬁcation, Protein G–Sepharose 4B resin (Sigma-
Aldrich, Poole, United Kingdom) and protein A–agarose (Sigma-
Aldrich)(1:1mix)werepacked intoaglasschromatographycolumn
(Bio-Rad, Hemel Hempstead, United Kingdom) to give a ﬁnal bed
volume of;1ml. Filtered supernatant was applied at a ﬂow rate of
0.5 to1ml/min.Thecolumnwaswashedwith$20columnvolumes
of PBS, andelutionwaswith0.1Mglycine (pH2.5) in 1ml fractions.
Fractions were neutralized with 1 M Tris base (pH unadjusted).
To concentrate the samples, the pooled fractions were trans-
ferred to 50 ml Falcon tubes and freeze-dried under vacuum
overnight. Lyophilized samples were resuspended in 200 ml
dH2O and dialyzed overnight against PBS.
Western blot analysis
Protein transfer was performed for 90 min onto a Hybond nitro-
cellulose membrane (GE Healthcare, Little Chalfont, United
Kingdom)at 0.4mA/cm2and50Vusing a semidryblottingdevice
(Bio-Rad). The membrane was incubated with 5% (w/v) nonfat
milk powder (Marvel Original dried skim milk) in Tris-buffered
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saline (TBS) for 30 min to block nonspeciﬁc binding sites. De-
tection of proteins was with goat antimurine IgG, Fcg subclass1
antiserum (115-035-205; Jackson ImmunoResearch Laboratories,
Newmarket, United Kingdom), and goat antimurine IgG, k light
chain speciﬁc antisera (115-035-174; Jackson ImmunoResearch
Laboratories) for 1 h at room temperature. The membrane was
washed5 timeswith 0.1%Tween-20 inTBS(5minperwash), then
developed using the ECL Plus Western blot detection system (GE
Healthcare, Little Chalfont, United Kingdom).
N-terminal sequencing
Puriﬁed mAb Guy’s 13 samples were separated by SDS-PAGE
on 4–15% gels (Bio-Rad), blotted on PVDF membrane, and
stained with Coomassie suspension G250. The N-terminal se-
quencing of mAb degradation fragments was performed by
M. Weldon (University of Cambridge) on a Procise Protein Se-
quencing System (Applied Biosystems, Foster City, CA, USA).
Densitometry
Band density from Western blot analysis was measured by densi-
tometry (GeneTools; Syngene, Cambridge, United Kingdom).
Individual inﬁltrationswereanalyzedbyStudent’s t test (P,0.05)
and the raw values for the fully assembled antibody compared to
the raw values of all other bands present in the samples.
ELISA
For quantiﬁcation of expressed mutant antibodies or functional
antigen binding ELISA, 96-well microtiter plates (NUNCMaxiSorp;
Thermo Fisher Scientiﬁc) were coated for 2 h at 37°C with cap-
ture antibody–antimurine k light chain (115-035-174; Jackson
ImmunoResearchLaboratories)at50ml/wellorwithrecombinant
E. coli–derived versionof SAI/II inPBSbuffernormally at 5mg/ml,
respectively. The plates were washed once with distilled H2O be-
fore blocking with 200 ml/well PBS buffer containing 5% (w/v)
nonfat milk powder for 2 h at 37°C, or overnight at 4°C. Samples
were loaded at 50 ml/well, titrated accordingly, and incubated for
2 h at 37°C. Plates were then washed 3 times with distilled H2O
containing 0.1% Tween-20 (H2O/T20). For detection, sec-
ondary antibody (antimurine g chain antiserum or antimurine
k chain antiserum; Sigma-Aldrich) labeled with horseradish
peroxidase (HRP) was added for 2 h at 37°C. Finally, the plates
were washed 3 times with H2O/T20 and developed with TMB
(3,39,5,59-tetramethylbenzidine) solution, 50 ml/well. The re-
action was stopped by adding 50 ml of 2 M H2SO4 and the plates
were read using a Sunrise plate reader (Tecan, Weymouth,
United Kingdom) at 450 nm. To determine antibody concen-
trations, a standard amountofquantiﬁed, commercially available
antibody was also used, and titrations wereﬁtted with a sigmoidal
dose–response curve to obtain the EC50 value (GraphPad Prism;
GraphPad Software, La Jolla, CA, USA).
RESULTS
Guy’s 13 fragmentation pattern
The murine monoclonal antibody (mAb) IgG1 Guy’s 13
was expressed by stable nuclear transformation or by
transient expression in N. tabacum. Leaf extracts were
separated by SDS-PAGE, and the presence of intact anti-
body as well as antibody fragments was detected by West-
ern blot analysis (Fig. 1). The results indicate close
similarity in the antibody fragments regardless of which
expression system was used. Detection with anti-Fc anti-
serum (Fig. 1A) identiﬁed 3 major bands at Mr ;180k
(band p, presumed to represent fully assembled anti-
body), Mr ;150k (band a), and Mr ;100k (band b) in
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Figure 1. Western blot analysis of mAb Guy’s 13
expressed in N. tabacum. Samples from mAb
expressed transgenically or transiently in N. tabacum
were separated on nonreducing 4–15% SDS-PAGE
gels, and proteins were blotted onto nitrocellulose
membrane. For detection, anti-Fc (A, lanes 1–3)
and anti-k (B, lanes 4–6) antisera were used.
Lanes 1 and 4, nontransgenic N. tabacum (WT);
lanes 2 and 5, crude leaf extract of transgenic N.
tabacum plants expressing Guy’s 13 (transgenic);
lanes 3 and 6, crude leaf extract from transiently
expressed mAb Guy’s 13 (transient). Asterisk
represents fully assembled antibody. Letters a–f
represent antibody fragments.
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both of the antibody-expressing plant samples, but not the
WT nontransgenic N. tabacum leaf extract (lane 1). A
similar result was obtained using an anti–k chain antise-
rum (Fig. 1B), although in this casemore immunoreactive
bands were observed. There were subtle differences be-
tween the relative intensities of individual bands—for ex-
ample, bands p and a are more intense in the transiently
expressed sample (Fig. 1B, lane 6), but bands b, c, and d are
more intense in the transgenic expression (Fig. 1B, lane 5).
Someminor bands were observed in one expression system
but not the other (e.g., Fig. 1B, bands e and f). Again, the
WT control N. tabacum demonstrated no immunoreactivity.
Identiﬁcation of N-terminal cleavage sites in mAb
Guy’s 13
Afﬁnity-puriﬁed Guy’s 13 fragments from a batch of tran-
siently expressedmAbwere separated by nonreducing SDS-
PAGE, transferred onto PVDF membrane, and stained
with Coomassie G250 (Fig. 2). The most prominent bands,
labeleda–f,werepresent asbefore, andEdmandegradation
was applied to these bands to analyze the amino acid se-
quences of their N termini. For bands a–c, N-terminal se-
quences were returned corresponding to the correctly
processed N termini of both the light and heavy chains. For
both fragments d and f, N-terminal sequences were identi-
ﬁed from within both the light and heavy chains. A single
light chain N-terminal amino acid sequence was identiﬁed
(EIKR), which resides within the junction between VL and
CL domains. Similarly, only a single heavy chain amino acid
sequence was identiﬁed (AKTT), which corresponds to the
junction between VH and CH1 domains.
Additionally, an N-terminal sequence was identiﬁed for
a band detected following SDS-PAGE under reducing
conditions (data not shown) atMr;17k, starting with the
amino acids RFSG which is found within the VL region of
Guy’s 13, near the boundary with CL.
Mutagenesis of heavy or light chains of mAb Guy’s 13
Having identiﬁed a very limited number of protease-
susceptible sites in the heavy and light chains of mAb
Guy’s 13, a series of mutations was designed up- and
downstream of the P1 and P19 amino acids (Fig. 3) and
expressed. Several mutagenesis approaches were consid-
ered: conservative substitution using amino acids with the
same physicochemical properties; nonconservative sub-
stitution using amino acids with divergent physicochemi-
cal properties; and structurally conservative amino acid
changes aimed at preserving the 3-dimensional structure
of the antibody. In theﬁrst 2 cases, aminoacid substitutions
were made using the Kabat database (28) to assess the
range of natural variants at these positions. If no possible
natural variantwas available in theKabat database, changes
were made using amino acids that were physicochemically
most similar/or divergent to the original Guy’s 13 residue.
In the last approach, in silicomodeling, performedwith the
molecular graphics programs Insight (Accelrys, SanDiego,
CA, USA) and RasMol (29), was used to choose substitute
amino acid residues, taking into account side chain inter-
actions so as not to interfere with the tertiary structure of
the antibody.
Four mutants were produced for the identiﬁed heavy
chain sequenceAKTT(Fig. 3), 2 representing conservative
substitutions (HC1 and HC3) and 2 representing non-
conservative substitutions (HC2 and HC4). Eight light
chain mutants were also produced, 2 representing con-
servative substitutions (LC1 and LC3), 2 representing
nonconservative substitutions (LC2 and LC4), and 4 rep-
resenting structurally conservative substitutions (LC5 to
LC8).
Expression and characterization of IgG mAb with
mutated heavy and light chains
Various combinations of heavy and light chains were
transiently expressed in N. tabacum. Extracts from inﬁl-
trated leaves were collected and analyzed by nonreducing
SDS-PAGE followed by Western blot analysis with anti-
murine k chain antiserum. Figure 4 illustrates the results
from 1 experiment that was representative of at least 3
repeat experiments for eachmutant antibody construct. In
some cases—for example, mutants LC5 and HC1—no
signiﬁcant differences were observed in mAb expression
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Figure 2. N-terminal sequencing
results of nonreduced mAb Guy’s
13 fragments. N-terminal sequenc-
ing of protein A/G–puriﬁed mAb
Guy’s 13 blotted onto PVDFmem-
brane and stained with Coomassie
G250. Arrows indicate position of
N-terminal sequence within heavy
and light chain amino acid se-
quence. Uppercase letters indi-
cate sequence returned from
N-terminal sequencing by Edman
degradation; lowercase letters in-
dicate major antibody fragments.
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when the mutated chains were coexpressed with the orig-
inal nonmutated corresponding immunoglobulin chain.
This was conﬁrmed by densitometry, which estimated the
percentage contribution of the full-length antibody band
(indicated in Fig. 4 by an asterisk) to be 16.8 and 26%
respectively, compared to 23.5% for coexpressed non-
mutated heavy and light chains. Similar results were
obtained with mutants HC3 and LC6 (not shown)
For both HC4 (coexpressed with nonmutated light
chain) and LC3 (coexpressed with nonmutated heavy
chain), there was a marked reduction in full-length mAb
expression. For HC4, no assembled mAb was detected,
whereas for LC3, full-length mAb represented only 5.4%
of the total immunodetected bands. A similar reduction
in full-length mAb yield was also observed for mutants
LC2 and LC4 (data not shown).
In 3 cases, an apparent increase in full-length mAb ac-
cumulations was observed even though there did not ap-
pear to be a signiﬁcant overall increase in light and heavy
chain expression. These were HC2 (coexpressed with
nonmutated light chain), LC1 and LC8 (coexpressed with
nonmutated heavy chain), and to some extent LC7 (data
not shown). In thecaseofHC+LC1, all thebands identiﬁed
in the nonmutated antibody were present, but the pro-
portionof full-length antibodywas enhanced. ForHC2+LC
andHC + LC8 combinations, bands f and c, and bands d, e,
and f were signiﬁcantly diminished, respectively. For HC2,
LC1, and LC8, the full-length mAb was the most prom-
inent band on the Western blot analysis, representing
between 36.5 and 43.8% of the total immunodetected
bands. No relationship was discerned between the mu-
tagenesis substitution strategy used and the effects on
antibody stability.
The assembled HC2 mutant IgG had an increased mo-
bility in antibody bands on membranes assessed by West-
ern blot analysis that was not seen with other mutants
(Fig. 4). Interestingly, this mobility shift affected all the
major bands detected in the Western blot analysis. Under
reducing conditions, no difference was observed between
the relative molecular masses of HC2, nonmutated heavy
chain, or other mutants (data not shown). Matrix-assisted
laser desorption/ionization time-of-ﬂight (MALDI-TOF)
mass spectrometry spectra of HC2 and HC were also
comparable (data not shown), indicating that the shift in
migration observed for HC2 mutant antibodies was not
due to a truncated heavy chain.
Coexpression of mutated heavy and light chains of
mAb Guy’s 13
IgG yieldwas also assessed for combinations ofHCmutants
withLCmutants (Fig. 5). Light chainmutants that hadhad
apositive effect (LC1,LC7, andLC8)ornoeffect (LC5and
Figure 3. Mutants of Guy’s 13 heavy
and light chain with substitutions prox-
imal to cleavage sites AKTT and EIKR.
WT Guy’s 13 heavy and light chain
sequence is shown in bold with corre-
sponding Kabat amino acid number-
ing. Location of protease cleavage site
is indicated by arrow, and positions
amino terminal (P1 to P6) and car-
boxyl terminal (P19 to P69) to scissile
bond are shown at top. Amino acid
sequences used in mutant heavy and
light chains are shown below, with amino
acid substitutions shown (unshaded).
Gray shading represents unchanged
amino acid residue.
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LC6) were coexpressed with HC1 (no effect) or HC2
(positive effect). None of the light chain mutants when
coexpressed with HC1 resulted in a greater yield of intact
IgG (Fig. 5A). This was irrespective of whether the light
chain mutant itself had individually resulted in an im-
provement in IgG yield (Fig. 4). When HC2mutant heavy
chain was coexpressed with LC5 or LC6, there was no en-
hanced IgG yield (Fig. 5B) even though HC2 with LC
(nonmutated) had previously resulted in improvement
(Fig. 4). The combination of HC2 with LC7 (both associ-
ated individually with improved IgG yield) did not result
in signiﬁcant improvement.
However, 2 combinations of HC and LC mutants did
result in signiﬁcant improvement of intact antibody yield.
These were HC2 with LC1 and HC2 with LC8 (Fig. 6). In
both cases, both the heavy chain mutant (HC2) and the
light chain mutants were associated individually with
higher yield of intact IgG (Fig. 4). For the HC2 + LC1
combination, both bands d and f were eliminated.
Replicate experiments were performed with 9 (HC2 +
LC1) and 6 (HC2 + LC8) independent inﬁltrations, and
the percentage of intact IgG was assessed by densitometry
(Fig. 7A,B). In eachcase, thenonmutatedHC+LCcontrol
was inﬁltrated into the sameplant. The data resulting from
densitometry analysis conﬁrmed the relative abundance of
the fully assembled antibody to its associated fragments.
All inﬁltrated mutant combinations (HC2 + LC1 and
HC2 + LC8) showed signiﬁcant differences in the per-
centage of fully assembled IgG compared to the IgG in the
control inﬁltration (HC + LC). In all cases, the percentage
of fully assembled antibody was approximately doubled
by introducing the mutations.
To conﬁrm that Guy’s 13 light and heavy chain mutants
retained binding activity to the relevant antigen (strepto-
coccal antigen I/II), a functional ELISA was performed
(Fig. 7C). Here, the positive control was an extract from
N. tabacum inﬁltrated with Guy’s 13 HC + LC. All anti-
body extracts were applied in triplicate at the same
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Figure 5. Transient coexpression of Guy’s 13 heavy and light chain mutants in N. tabacum. Nonreducing Western blot analysis of
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Figure 4. Transient expression of Guy’s 13
heavy and light chain mutants in N. tabacum.
Nonreducing Western blot analysis of leaf
extracts from transiently expressed Guy’s 13
heavy chain mutants (HC1, HC2, and HC4)
expressed together with nonmutated Guy’s 13
light chain (LC) and light chain mutants (LC1,
LC3, LC5, and LC8) together with nonmutated
Guy’s 13 heavy chain (HC). Detection was with
HRP-conjugated antimurine k chain antiserum.
Control was nonmutated Guy’s 13 heavy and
light chains (HC + LC). Asterisk indicates
fully assembled IgG. Letters a–f indicate major
antibody fragments.
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concentration, as determined previously by quantita-
tion ELISA (data not shown). Detection of antibody
bound to SAI/II was with an HRP-conjugated anti-
murine k chain antibody. All mutants demonstrated a
clear positive signal indicating that they were assembled
and bound to SAI/II. EC50 dilutions were calculated for
each antibody and are shown in Fig. 7C. There were no
signiﬁcant differences between the control HC + LC
and any of the mutants (Student’s t test, P , 0.05).
DISCUSSION
The development and use of recombinant monoclonal
antibodies (mAbs) represents one of the leading research
areas for therapeutics diagnostics and vaccine develop-
ment. Alternative expression platforms such as plants are
being explored to address issues of cost and scalability,
especially for applications targeted to resource-poor
regions. However, fully assembled antibody in plants is
usually accompanied by additional immunoglobulin
species of lower molecular weight, which are pre-
dominately generated by enzymatic action of plant pro-
teases (6, 7, 23). This consistent problem reduces yields,
complicates downstream processing, and increases pro-
duction costs (30).
Plant proteases are often pivotal to maintaining meta-
bolic functions, so in this study, we developed an approach
of modiﬁcation of speciﬁc proteolytic target sequences in
a monoclonal antibody to improve expression in plants.
This could be achieved without affecting antibody assem-
bly and function. Our previous ﬁndings with other
monoclonal antibodies had indicated the presence in
antibodies of a limited number of conserved cleavage
sites that are located in interdomain and solvent-
exposed regions of the light and heavy chains (5). These
ﬁndings were conﬁrmed here using a murine IgG
mAb by N-terminal sequencing of antibody fragments
present in crude plant extract. In particular, an impor-
tant cleavage site (EIKR) was identiﬁed in the light chain
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Figure 7. Densitometric analysis of antibody assembly from Western blot analysis. Percentage of fully assembled antibody was
measured by densitometry of 9 biologic repeats for HC2 + LC1 and HC2 + LC8. Data presented as means 6 SD. A, B)
Independent inﬁltrations from Nicotiana tabacum of nonmutated Guy’s 13 control (HC + LC) was compared by Student’s
t test (P , 0.05) to inﬁltrated mutants HC2 + LC1 (A) and HC2 + LC8 (B). *P , 0.05; **P , 0.005. C ) Antigen binding
activity for Guy’s 13 mutants. Equivalent amounts of each antibody preparation were serially diluted on ELISA plate coated
with SAI/II. Bound antibody was detected with HRP-conjugated antimurine k chain reagent. Absorbance values were
plotted against dilutions. Titrations were ﬁtted using sigmoidal dose–response curve (GraphPad Prism) and EC50 values
calculated.
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Figure 6. Transient coexpression of Guy’s 13
heavy and light chain mutants in N. tabacum.
Nonreducing Western blot analysis of leaf
extracts from inﬁltrated Guy’s 13 heavy chain
mutant (HC2) coexpressed with Guy’s 13 light
chain mutants (LC1 or LC8). Detection was
with HRP-conjugated antimurine k chain anti-
serum. Control was nonmutated Guy’s 13 heavy
and light chains (HC + LC). Asterisk indicates
fully assembled IgG.
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at the junction of VL and CL, and similarly, a major site
(AKTT) was found in the heavy chain at the junction of
VH and CH1. Whether EIKR and AKTT actually rep-
resent the exact N terminus of a newly cleaved poly-
peptide remains to be determined, as it is possible that
primary cleavage upstream of these sites might be fol-
lowed by further trimming by other proteases. Other
proteolytic sites toward the C terminus of light and
heavy chains are likely, and indeed predicted, from our
results, but despite extensive analysis, no other new
cleavage sites have been identiﬁed in the variable do-
mains or in the constant or CH1 domains of light and
heavy chains, respectively.
Previous studies have demonstrated the principle of
antibody engineering to enhance stability. For example,
the stability of human IgA1 against bacterial proteases
was enhanced through engineering of a hybrid hinge re-
gion comprising half of human IgA1 and human IgA2
hinge region (31). Peters et al. (32) demonstrated that
mutations introduced into the CH1 domain of IgG4 in-
creased antibody thermal stability by mimicking the in-
terchaindisulﬁdebondarrangementsobserved in IgG1. In
our study, a range of mutations targeted at the EIKR and
AKTT sites in the antibody light and heavy chains were
examined. Sequences were identiﬁed that abolished or
signiﬁcantly diminished full-length antibody yield, had no
apparent effect, or enhanced full-length antibody yield.
Although different approaches were used to design the
mutations, no consistent relationship between mutation
strategy and antibody yield was evident, so at this stage, a
mechanism of action can only be speculated on. One
possibility is that the change to amore hydrophobic amino
acid in position 113 (Ser113Val) and a basic amino acid in
position 114 (Ala114His) of Guy’s 13 heavy chain (mutant
HC2)may alter the accessibility of the site, as both residues
were found in a solvent-exposed interdomain region.
Proteins typically fold in such a way as to minimize solvent
exposure of the hydrophobic amino acids while exposing
the hydrophilic residues. Appropriate presentation of a
potential cleavage site in an exposed and unstructured
region (such as a solvent-exposed loop) would be a mini-
mal requirement for hydrolysis. The replacement of polar
amino acids for hydrophobic amino acids (as done in
mutant HC2) might prevent or slow down access to the
cleavage site.
Of interest was the ﬁnding that an alteration in the light
chain, for example, LC8, could result in the loss ofmultiple
bands, including, apparently, those linked to heavy chain
degradation. This led us to consider the likelihood that
antibodies expressed in plants are cleaved by different
proteases in a sequential manner. Thus, proteolysis at an
initial site on the light chain might allow subsequent pro-
tease access to additional amino acid sequences previously
buried within the antibody structure, including the heavy
chain. Similar ﬁndings have been reported—for example,
in the case of sphingosin kinase 1 (SK1) cleavage by
cathepsin B. Site-directed mutagenesis of an initial target
site not only abrogated a Mr 30k degradation band and
stabilized intact SK1but also reduced the appearance of an
additionalMr 18k fragment (33).
An unexpected ﬁnding was that the expression of HC2
mutant combinations was associated with a consistent
shift in apparent molecular mass on PAGE relative to the
control (HC + LC) and molecular weight marker. The
possibility of a truncated HC2 mutant, cleaved by prote-
ases, was excluded by MALDI-TOF analysis (data not
shown). A comparison of the calculated pIs for the WT
HC (pI = 6.55) and the HC2 (pI = 6.59) revealed only a
minor effect on the overall charge of the HC2 mutant.
Changes in hydrophobicity of the HC2 mutant may ex-
plain the phenomenon of gel shifting, as Val113 is more
hydrophobic than the substituted Ser113, whereas His114
is a more basic, cationic amino acid than Ala114 (34).
The next stage of this work will be to extend the analysis
of protease cleavage sites to other similar antibodies in
order to identify common and consistent target peptide
motifs. It should ultimately be possible to perform more
extensive screening of mutation strategies and to assess
combination approaches that provide maximum IgG
protection. The initial ﬁndings reported here for a
monoclonal antibody could, of course, be extended to
other recombinant proteins expressed in plants. In ad-
dition, the targeted mutation approach could be used to
complement strategies that involve protease inhibition
(23) and/or plant protease knockout (7) that are being
adopted elsewhere, alongsidemultiple other approaches
to maximize recombinant protein accumulation in plant
systems.
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